Answers are grounded in this paper and cite their sources.
We read with interest the recent article by Kunz et al . [1] in the European Respiratory Journal ( ERJ ), and the appropriately questioning accompanying editorial by Calverley [2] in the same issue, considering airway inflammation and effects of inhaled corticosteroids (ICS) in chronic obstructive pulmonary disease (COPD). Understanding COPD pathology is a hugely important area and it is encouraging that leading respiratory journals are recognising this. We would like to suggest that a broader discussion of new insights into COPD pathology might have been appropriate. Thus, a more integrated consideration of overall airway wall cellularity, vascularity, epithelial–mesenchymal transition (EMT) and the effects of ICS on these in COPD is urgently needed to aid discussion of this devastating pathophysiology. There is a need for in-depth discussion of new insights in COPD airway pathogenesis <http://ow.ly/RDFM30bxduu>
No takes yet. Share an insight, caveat, or question.
Sohal et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: